AI assistant
Sending…
CYTOKINETICS INC — Director's Dealing 2021
Jul 2, 2021
30870_dirs_2021-07-02_5c5db5d8-9423-46e0-a8d5-25c16190eafa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2021-07-01
Reporting Person: Cragg David (Chief HR & Admin Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-07-01 | Common Stock | S | 6013 | $19.8701 | Disposed | 155158 | Direct |
Footnotes
F1: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2021.
F2: Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan.
More from CYTOKINETICS INC
Share Issue/Capital Change
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 27
Share Issue/Capital Change
2026
May 7
Report Publication Announcement
2026
May 5
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18